Over time, muscle degeneration can become so excessive as to result in respiratory and cardiovascular issues, leading to respiratory or cardiac arrest and death. Currently, people with LGMD2I have no treatment options beyond steroid injections and other symptom and pain management techniques. The LGMD2I community has made exceptional strides to spread awareness of the unmet medical need, as well as to create a network connecting patients with physician experts in the field of neuromuscular diseases.
| Website | http://mlbiosolutions.com |
| Revenue | $1 million |
| Employees | 8 (3 on RocketReach) |
| Address | 100 N Tryon St Ste 4100, Charlotte, North Carolina 28202, US |
| Phone | +1 224-504-2600 |
| Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
| Keywords | Muscular Dystrophy, Cardiovascular Disease, Muscle Health, Genetic Muscle Disease, Rare Disease Research, Gene Therapy, Therapeutic Development, Biotechnology Solutions, Regenerative Medicine, Biomarker Discovery, Precision Medicine, Drug Discovery, Pharmaceutical Research, Disease Modeling, Biomedical Research, Clinical Trials, Health Technology |
| Competitors | Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, Bio-Rad Laboratories, Genomatix AG, Roche, MilliporeSigma, PerkinElmer, Inc., Biotechne Complex Inc +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular ML Bio Solutions employee's phone or email?
The ML Bio Solutions annual revenue was $1 million in 2026.
Anna Wade is the COO of ML Bio Solutions.
3 people are employed at ML Bio Solutions.
ML Bio Solutions is based in Charlotte, North Carolina.
The NAICS codes for ML Bio Solutions are [32541, 325414, 325, 32, 3254].
The SIC codes for ML Bio Solutions are [28, 283].